Nanotechnology: Emerging Developments and Early Detection of Cancer. A Two-Day Workshop sponsored by the National Cancer Institute and the National Institute of Standards and Technology, August 30–31 2001, on the National Institute of Standards and Technology Campus, Gaithersburg, MD, USA

Article type: Research Article

Authors: Zullo, Steven J. | Srivastava, Sudhir | Looney, J. Patrick | Barker, Peter E.

Affiliations: Chemistry and Life Sciences Division, Advanced Technology Program, National Institute of Standards and Technology, Gaithersburg, MD 20899-4730, USA | Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Plaza North, Suite 3142, Bethesda, MD 20892, USA | Program Office, National Institute of Standards and Technology, Gaithersburg, Md 20899-8311, USA | NIST-NCI Biomarkers Validation Laboratory, DNA Technology Group/ Biotechnology Division, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, MD 20899-8311, USA

Abstract: A recent meeting jointly sponsored by the National Cancer Institute (NCI) and National Institute of Standards and Technology (NIST) brought together researchers active in nanotechnology and cancer molecular biology to discuss and evaluate the interface between disciplines. Emerging areas where nanotechnologies may impact cancer prevention and early cancer detection were elaborated by key researchers who catalyzed interdisciplinary dialogue aimed at fostering cross-discipline communications and future collaboration.

Keywords: biomarker, cancer detection, nanotechnology, high throughput, microarray, mitochondria

Journal: Disease Markers, vol. 18, no. 4, pp. 153-158, 2002